Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Medtronic
Teva
US Department of Justice
UBS
Johnson and Johnson
Express Scripts
Harvard Business School
McKinsey

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088486

« Back to Dashboard

NDA 088486 describes METHYCLOTHIAZIDE AND DESERPIDINE, which is a drug marketed by Watson Labs and is included in two NDAs. Additional details are available on the METHYCLOTHIAZIDE AND DESERPIDINE profile page.

The generic ingredient in METHYCLOTHIAZIDE AND DESERPIDINE is deserpidine; methyclothiazide. There are four drug master file entries for this compound. Additional details are available on the deserpidine; methyclothiazide profile page.
Summary for 088486
Tradename:METHYCLOTHIAZIDE AND DESERPIDINE
Applicant:Watson Labs
Ingredient:deserpidine; methyclothiazide
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.25MG;5MG
Approval Date:Aug 10, 1984TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Express Scripts
Dow
Cerilliant
Covington
US Army
Cipla
Daiichi Sankyo
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.